I agree that this site is using cookies. You can find further informations here.
X
Gray Heppner Jr, D.
75  results:
Search for persons X
?
1

Sequential Phase 1 and Phase 2 randomized, controlled trial..:

Kester, Kent E. ; Gray Heppner Jr, D. ; Moris, Philippe...
Vaccine.  32 (2014)  49 - p. 6683-6691 , 2014
Link: https://doi.org/10.1016/..
 
?
2

Phase 1 randomized double-blind safety and immunogenicity t..:

Stoute, José A. ; Gombe, Joash ; Withers, Mark R....
Vaccine.  25 (2007)  1 - p. 176-184 , 2007
Link: https://doi.org/10.1016/..
 
?
3

Randomized Trial of 3-Dose Regimens of Tafenoquine (WR23860..:

Douglas S. Walsh ; Polrat Wilairatana ; Douglas B. Tang...
Clinical Infectious Diseases.  39 (2004)  8 - p. 1095-1103 , 2004
Link: https://www.jstor.org/st..
 
?
4

Results from tandem Phase 1 studies evaluating the safety, ..:

Otsyula, Nekoye ; Angov, Evelina ; Bergmann-Leitner, Elke...
Malaria Journal.  12 (2013)  1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
5

Expression of Genes Associated with Immunoproteasome Proces..:

Vahey, Maryanne T. ; Wang, Zhining ; Kester, Kent E....
The Journal of Infectious Diseases.  201 (2010)  4 - p. 580-589 , 2010
Link: https://doi.org/10.1086/..
 
?
6

Expression of Genes Associated with Immunoproteasome Proces..:

Vahey, Maryanne T. ; Wang, Zhining ; Kester, Kent E....
The Journal of Infectious Diseases.  201 (2010)  4 - p. 580-589 , 2010
Link: https://www.jstor.org/st..
 
?
7

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with A..:

Cummings, James F. ; Spring, Michele D. ; Schwenk, Robert J....
Vaccine.  28 (2010)  31 - p. 5135-5144 , 2010
Link: https://doi.org/10.1016/..
 
?
8

Cell-mediated immunity elicited by the blood stage malaria ..:

Lyke, Kirsten E. ; Daou, Modibo ; Diarra, Issa...
Vaccine.  27 (2009)  15 - p. 2171-2176 , 2009
Link: https://doi.org/10.1016/..
 
?
9

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Mala..:

Kester, Kent E. ; Cummings, James F. ; Ofori‐Anyinam, Opokua...
The Journal of Infectious Diseases.  200 (2009)  3 - p. 337-346 , 2009
Link: https://doi.org/10.1086/..
 
?
10

Randomized, Double-Blind, Phase 2a Trial of Faltiparum Mala..:

Kester, Kent E. ; Cummings, James F. ; Ofori-Anyinam, Opokua...
The Journal of Infectious Diseases.  200 (2009)  3 - p. 337-346 , 2009
Link: https://www.jstor.org/st..
 
?
11

Improved T cell responses to Plasmodium falciparum circumsp..:

Mettens, Pascal ; Dubois, Patrice M. ; Demoitié, Marie-Ange...
Vaccine.  26 (2008)  8 - p. 1072-1082 , 2008
Link: https://doi.org/10.1016/..
 
?
12

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day im..:

Kester, Kent E. ; Cummings, James F. ; Ockenhouse, Christian F....
Vaccine.  26 (2008)  18 - p. 2191-2202 , 2008
Link: https://doi.org/10.1016/..
 
?
13

Phase I dose escalation safety and immunogenicity trial of ..:

Polhemus, Mark E. ; Magill, Alan J. ; Cummings, James F....
Vaccine.  25 (2007)  21 - p. 4203-4212 , 2007
Link: https://doi.org/10.1016/..
 
?
14

Hb G‐Philadelphia or Stanleyville II? When the phenotype an..:

Waitumbi, John N. ; Kifude, Carolyne M. ; Withers, Mark R....
European Journal of Haematology.  79 (2007)  2 - p. 177-178 , 2007
Link: https://doi.org/10.1111/..
 
?
15

A phase I/IIa safety, immunogenicity, and efficacy bridging..:

Kester, Kent E. ; McKinney, Denise A. ; Tornieporth, Nadia...
Vaccine.  25 (2007)  29 - p. 5359-5366 , 2007
Link: https://doi.org/10.1016/..
 
1-15